Cell Analysis Global Market - Forecast to 2023

Publishing Date : January, 2017
Report Code : HCBT0103
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Cells are the biological units that are used for the identification and mapping of the basic biochemical and physical processes of life. Analysis of these cells plays a major role in gene identification, protein identification, transcription analysis and epigenomics at the cellular level by revealing the heterogenocity of the the cells. Hospitals, academic institutions, government institutes, as well as pharmaceutical and biotechnology firms are increasing their focus on the application of cell analysis as a modern emerging tool in research, drug discovery and diagnosis. The cell analysis techniques global market is segmented into molecular approaches and image-based approaches. The molecular approaches include the PCR, sequencing techniques, microarray and microfluidics, cell isolation and separation techniques performed at cells genomic level. Real-time PCR and Digital PCR are the two PCR techniques. Sequencing techniques are segmented into DNA sequencing, RNA sequencing, and protein sequencing. Cell isolation and separation techniques include centrifugation, cell surface based separation, filtration based cell separation and other separation techniques. Microcentrifugation, high-speed centrifugation, and ultracentrifugation are the types of the centrifugation process. Among molecular approaches PCR accounted for the largest share and sequencing is expected to grow at highest CAGR from 2016-2023.

This image-based approach of cell analysis technology global market is segmented into microscopy, cytometry, high content screening, FISH, and Spectrophotometers. Microscopy types are optical microscopy, electron microscopy and scanning probe microscopy (SPM). Under optical microscopy, the types are fluorescence microscopy and confocal microscopy. Stimulated Emission Depletion (STED), Total Internal Reflection Fluorescence (TIRF), Fluorescence Recovery after Photobleaching (FRAP) and Laser Capture Microdissection are the types of fluorescence microscopy.  Under electron microscopy, the types are Scanning Electron Microscope (SEM), Transmission Electron Microscopy (TEM) and Cryo-Electron Tomography (Cryo-ET). Among image based approaches Cytometry generated the largest revenue and FISH is expected to grow at double digit CAGR from 2016-2023. 

The cell analysis products market is mainly segmented into consumables, instruments, software and services. The consumables include reagents, assay plates, microplates, cell culture consumables and others. The instrument segment comprises of cell counters, microscopes, cell isolation and separation instruments, cytometers, spectrophotometer, Sequencing instruments, PCR devices, microfluidic devices, high content screening (HCS) systems and cell microarrays. Cell counters types are hemocytometers, automated cell counters, coulter counters and others cell counters. Cytometers types are flow cytometers, laser scanning cytometer, and imaging cytometer. Spectrophotometers include microplate readers, fluorescent spectrophotometers and calorimeters. Microscopes types are electron microscopes, inverted microscopes, stereo microscopes, fluorescence and confocal microscopes, phase contrast microscopes and other microscopes.

By application, the market is segmented into by processes, by field, and by therapeutic area. By process of application, the market is segmented into cellular processes, signal transduction pathways, circulating tumor cells, single cell analysis, epigenetic target analysis, subpopulation characterization, and drug and candidate screening. Cellular process application accounted for a largest revenue and the single cell analysis market is expected to boom at a high CAGR from 2016-2023. By field of application, the market is further segmented into forensic, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. Diagnostics is holding the largest revenue in 2016 and stem cell analysis is expected to grow at a high CAGR from 2016-2023. By therapeutic area, the market is further segmented into cancer research, infectious disease diagnosis, genetic testing, immunology, and others. The immunology accounted for largest revenue in 2016 and genetic testing is expected to grow at a strong CAGR from 2016-2023.

By end-users, the market is segmented into hospitals, academic and research institutes, contract research organizations (CROs), pharmaceuticals and biotechnology companies, cell banks, diagnostic laboratories and others. Academic and research institutes generated the largest revenue in 2016 and the Contract Research Organizations are expected to grow at high CAGR from 2016-2023.

By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the cell analysis market. Drug discovery services outsourcing and government funding for novel screening technologies have resulted in a growth of Asian markets.

The cell analysis market is expected to grow at high single digit CAGR to reach $47,088 million by 2023. The major factor influencing the growth is enhanced precision of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process. In addition, the factors like increasing incidence of cancer, increasing government investments, funds, and grants, availability of reagents and cell analysis instruments are driving the growth of the market. However, the major market restraints include high capital investments and a shortage of skilled labor for the high content screening procedure. The biggest opportunities for this market is the emerging APAC market, high content screening services provided by contract research organizations, automation in cancer research for its early diagnosis and reduction of cost in the cancer treatment.

The cell analysis global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the cell analysis global market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K.), Merck KGAA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands) and ThermoFisher Scientific, Inc. (U.S.). In order to offer the products with better software, most of the players in the cell analysis market are collaborating with companies and educational institutions.

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World (RoW)

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKE AWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN & DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.5     PRIMARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     RISING INCIDENCE OF LIFE THREATENING INFECTIOUS DISEASES
        • 3.3.1.2     INCREASING GOVERNMENT, CORPORATE FUNDING AND INVESTMENT IN CELLBASED RESEARCH
        • 3.3.1.3     INTRODUCTION OF ENHANCED CELL IMAGING AND ANALYSIS SYSTEM REDUCES THE COST AND TIME CONSUMPTION FOR DRUG DISCOVERY PROCESS
        • 3.3.1.4     AVAILABILITY OF ADVANCED CELL ANALYSIS INSTRUMENTS
        • 3.3.1.5     INCREASING DEMAND FOR CELL ANALYSIS PRODUCTS BY END USERS
        • 3.3.1.6     EMERGING ASIA PACIFIC CELL ANALYSIS MARKET
        • 3.3.1.7     INCREASED AVAILABILITY OF CELL ANALYSIS SERVICE PROVIDERS
        • 3.3.1.8     AUTOMATION IN ONCOLOGY RESEARCH FOR EARLY DIAGNOSIS
      • 3.3.2     RESTRAINTS & THREATS
        • 3.3.2.1     LACK OF SKILLED PERSONNEL TO PERFORM HIGH CONTENT SCREENING
        • 3.3.2.2     EXPENSIVE CELL ANALYSIS INSTRUMENTS
        • 3.3.2.3     STRINGENT REGULATORY FRAMEWORK LIMITS ADVANCEMENTS IN CELLULAR ANALYSIS MARKET
        • 3.3.2.4     PATENTS OR IPR ISSUES HINDERING THE CELL ANALYSIS MARKET
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     U.S.
      • 3.4.2     EUROPE
      • 3.4.3     CHINA
      • 3.4.4     INDIA
      • 3.4.5     JAPAN
    • 3.5     PORTER’S FIVE FORCE ANALYSIS
      • 3.5.1     THREAT OF NEW ENTRANTS
      • 3.5.2     THREAT OF SUBSTITUTES
      • 3.5.3     COMPETITIVE RIVALRY
      • 3.5.4     BARGAINING POWER OF SUPPLIERS
      • 3.5.5     BARGAINING POWER OF BUYERS
    • 3.6     LATEST AND UPCOMING PRODUCTS
    • 3.7     ONGOING RESEARCHES AND FUNDING SCENARIO
    • 3.8     SUPPLY CHAIN ANALYSIS
    • 3.9     LIVE CELL IMAGING
    • 3.10     MARKET SHARE ANALYSIS
      • 3.10.1     MARKET SHARE ANALYSIS BY CELL ANALYSIS MAJOR PLAYERS
      • 3.10.2     MARKET SHARE ANALYSIS BY SINGLE CELL ANALYSIS MAJOR PLAYERS
  • 4     CELL ANALYSIS GLOBAL MARKET, BY TECHNIQUES
    • 4.1     INTRODUCTION
    • 4.2     MOLECULAR APPROACHES
      • 4.2.1     PCR (POLYMERASE CHAIN REACTION)
      • 4.2.2     SEQUENCING
      • 4.2.3     MICROFLUIDICS AND MICROARRAYS
        • 4.2.3.1     MICROFLUIDICS
        • 4.2.3.2     MICROARRAY
      • 4.2.4     CELL ISOLATION AND SEPARATION
    • 4.3     IMAGE BASED APPROACHES
      • 4.3.1     MICROSCOPY
      • 4.3.2     CYTOMETRY
      • 4.3.3     HIGH CONTENT SCREENING
      • 4.3.4     FISH (FLUOROSCENCE IN-SITU HYBRIDIZATION)
      • 4.3.5     SPECTROPHOTOMETRY
  • 5     CELL ANALYSIS GLOBAL MARKET, BY PRODUCTS
    • 5.1     INTRODUCTION
    • 5.2     CONSUMABLES
      • 5.2.1     ASSAY KITS
      • 5.2.2     REAGENTS
      • 5.2.3     MICROPLATES
      • 5.2.4     CELL CULTURE CONSUMABLES
      • 5.2.5     OTHERS
    • 5.3     INSTRUMENTS
      • 5.3.1     CELL COUNTERS
      • 5.3.2     CELL MICROARRAYS
      • 5.3.3     CELL ISOLATION AND SEPERATION INSTRUMENTS
      • 5.3.4     CYTOMETERS
      • 5.3.5     HIGH CONTENT SCREENING SYSTEMS
      • 5.3.6     MICROFLUIDIC DEVICES
      • 5.3.7     PCR INSTRUMENTS
      • 5.3.8     SEQUENCING INSTRUMENTS
      • 5.3.9     SPECTROPHOTOMETERS
      • 5.3.10     MICROSCOPES
      • 5.3.11     OTHER INSTRUMENTS
    • 5.4     SOFTWARES AND SERVICES
  • 6     CELL ANALYSIS GLOBAL MARKET, BY APPLICATION
    • 6.1     INTRODUCTION
    • 6.2     CELL ANALYSIS GLOBAL MARKET, BY PROCESS OF APPLICATION
      • 6.2.1     CELLULAR PROCESSES
      • 6.2.2     SIGNAL TRANSDUCTION PATHWAY
      • 6.2.3     CIRCULATING TUMOR CELLS
      • 6.2.4     SINGLE CELL ANALYSIS
      • 6.2.5     EPIGENETIC TARGET ANALYSIS
      • 6.2.6     SUBPOPULATION CHARACTERIZATION
      • 6.2.7     DRUG AND CANDIDATE SCREENING
    • 6.3     CELL ANALYSIS GLOBAL MARKET, BY FIELD OF APPLICATION
      • 6.3.1     FORENSICS
      • 6.3.2     THERAPEUTICS
      • 6.3.3     GENOMIC ANALYSIS
      • 6.3.4     STEM CELL ANALYSIS
      • 6.3.5     BIOMARKER RESEARCH
      • 6.3.6     CELL IMAGING
      • 6.3.7     DIAGNOSTICS
    • 6.4     CELL ANALYSIS GLOBAL MARKET, BY THERAPEUTIC AREA OF APPLICATIONS
      • 6.4.1     CANCER RESEARCH
      • 6.4.2     GENETIC TESTING
      • 6.4.3     INFECTIOUS DISEASES
      • 6.4.4     IMMUNOLOGY
      • 6.4.5     OTHERS
  • 7     CELL ANALYSIS GLOBAL MARKET, BY END-USERS
    • 7.1     INTRODUCTION
    • 7.2     HOSPITALS
    • 7.3     ACADEMIC & RESEARCH LABORATORIES
    • 7.4     DIAGNOSTIC LABORATORIES
    • 7.5     PHARMACEUTICALS AND BIOTECH COMPANIES
    • 7.6     CONTRACT RESEARCH ORGANISATIONS
    • 7.7     CELL BANKS
    • 7.8     OTHERS
  • 8     REGIONAL MARKET ANALYSIS
    • 8.1     INTRODUCTION
    • 8.2     NORTH AMERICA
    • 8.3     EUROPE
    • 8.4     ASIA PACIFIC
    • 8.5     REST OF THE WORLD
  • 9     COMPANY DEVELOPMENTS
    • 9.1     INTRODUCTION
      • 9.1.1     NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF CELL ANALYSIS MARKET PLAYERS
    • 9.2     NEW PRODUCT LAUNCH
    • 9.3     AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES
    • 9.4     MERGERS AND ACQUISITIONS
    • 9.5     APPROVAL
    • 9.6     BUSINESS EXPANSION
  • 10     MAJOR PLAYER PROFILES
    • 10.1     AGILENT TECHNOLOGIES, INC.
      • 10.1.1     OVERVIEW
      • 10.1.2     FINANCIALS
      • 10.1.3     PRODUCT PORTFOLIO
      • 10.1.4     KEY DEVELOPMENTS
      • 10.1.5     BUSINESS STRATEGY
      • 10.1.6     SWOT ANALYSIS
    • 10.2     BECKTON DICKENSON AND COMPANY
      • 10.2.1     OVERVIEW
      • 10.2.2     FINANCIALS
      • 10.2.3     PRODUCT PORTFOLIO
      • 10.2.4     KEY DEVELOPMENTS
      • 10.2.5     BUSINESS STRATEGY
      • 10.2.6     SWOT ANALYSIS
    • 10.3     BIO-RAD LABORATORIES
      • 10.3.1     OVERVIEW
      • 10.3.2     FINANCIALS
      • 10.3.3     PRODUCT PORTFOLIO
      • 10.3.4     KEY DEVELOPMENTS
      • 10.3.5     BUSINESS STRATEGY
      • 10.3.6     SWOT ANALYSIS
    • 10.4     DANAHER CORPORATION
      • 10.4.1     OVERVIEW
      • 10.4.2     FINANCIALS
      • 10.4.3     PRODUCT PORTFOLIO
      • 10.4.4     KEY DEVELOPMENTS
      • 10.4.5     BUSINESS STRATEGY.
      • 10.4.6     SWOT ANALYSIS
    • 10.5     GE HEALTHCARE
      • 10.5.1     OVERVIEW
      • 10.5.2     FINANCIALS
      • 10.5.3     PRODUCT PORTFOLIO
      • 10.5.4     KEY DEVELOPMENTS
      • 10.5.5     BUSINESS STRATEGY
      • 10.5.6     SWOT ANALYSIS
    • 10.6     MERCK KGAA
      • 10.6.1     OVERVIEW
      • 10.6.2     FINANCIALS
      • 10.6.3     PRODUCT PORTFOLIO
      • 10.6.4     KEY DEVELOPMENTS
      • 10.6.5     BUSINESS STRATEGY
      • 10.6.6     SWOT ANALYSIS
    • 10.7     OLYMPUS CORPORATION
      • 10.7.1     OVERVIEW
      • 10.7.2     FINANCIALS
      • 10.7.3     PRODUCT PORTFOLIO
      • 10.7.4     KEY DEVELOPMENTS
      • 10.7.5     BUSINESS STRATEGY
      • 10.7.6     SWOT ANALYSIS
    • 10.8     PERKINELMER, INC.
      • 10.8.1     OVERVIEW
      • 10.8.2     FINANCIALS
      • 10.8.3     PRODUCT PORTFOLIO
      • 10.8.4     KEY DEVELOPMENTS
      • 10.8.5     BUSINESS STRATEGY
      • 10.8.6     SWOT ANALYSIS
    • 10.9     PROMEGA CORPORATION
      • 10.9.1     OVERVIEW
      • 10.9.2     FINANCIALS
      • 10.9.3     PRODUCT PORTFOLIO
      • 10.9.4     KEY DEVELOPMENTS
      • 10.9.5     BUSINESS STRATEGY
      • 10.9.6     SWOT ANALYSIS
    • 10.10     QIAGEN N V
      • 10.10.1     OVERVIEW
      • 10.10.2     FINANCIALS
      • 10.10.3     PRODUCT PORTFOLIO
      • 10.10.4     KEY DEVELOPMENTS
      • 10.10.5     BUSINESS STRATEGY
      • 10.10.6     SWOT ANALYSIS
    • 10.11     THERMOFISHER SCIENTIFIC INC.
      • 10.11.1     OVERVIEW
      • 10.11.2     FINANCIALS
      • 10.11.3     PRODUCT PORTFOLIO
      • 10.11.4     KEY DEVELOPMENTS
      • 10.11.5     BUSINESS STRATEGY
      • 10.11.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 2     CELL ANALYSIS GLOBAL MARKET REVENUE, BY TECHNIQUE, (2015-2023) ($MN)
      • TABLE 3     CELL ANALYSIS GLOBAL MARKET REVENUE, BY PRODUCTS,(2015-2023) ($MN)
      • TABLE 4     CELL ANALYSIS GLOBAL MARKET REVENUE, BY PROCESS OF APPLICATION (2015-2023) ($MN)
      • TABLE 5     CELL ANALYSIS GLOBAL MARKET REVENUE, BY FIELD OF APPLICATION (2015-2023) ($MN)
      • TABLE 6     CELL ANALYSIS GLOBAL MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION (2015-2023) ($MN)
      • TABLE 7     CELL ANALYSIS GLOBAL MARKET REVENUE, BY END USERS,(2015-2023) ($MN)
      • TABLE 8     CELL ANALYSIS GLOBAL TECHNIQUES MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 9     CELL ANALYSIS GLOBAL MARKET REVENUE, BY TECHNIQUE, (2015-2023) ($MN)
      • TABLE 10     MOLECULAR BASED CELL ANALYSIS APPROACH GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 11     MOLECULAR BASED CELL ANALYSIS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 12     PCR TECHNIQUE IN CELL ANALYSIS GLOBAL MARKET REVENUE,BY REGION, (2015-2023) ($MN)
      • TABLE 13     SEQUENCING TECHNIQUE IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 14     MICROFLUIDICS AND MICROARRAY IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 15     MICROFLUIDIC AND MICROARRAY IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 16     MICROFLUIDICS IN CELL ANALYSIS GLOBAL MARKET REVENUE,BY REGION, (2015-2023) ($MN)
      • TABLE 17     MICROARRAYS IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 18     CELL ISOLATION AND SEPERATION IN CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 19     IMAGE-BASED CELL ANALYSIS APPROACHES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 20     IMAGE BASED CELL ANALYSIS APPROACH GLOBAL MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 21     MICROSCOPY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 22     CYTOMETRY CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 23     HIGH CONTENT SCREENING CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 24     FISH (FLUORESCENT IN-SITU HYBRIDIZATION) CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 25     SPECTROPHOTOMETRY CELL ANALYSIS GLOBAL MARKET REVENUE,BY REGION, (2015-2023) ($MN)
      • TABLE 26     CELL ANALYSIS GLOBAL MARKET, BY PRODUCTS (2015-2023) ($MN)
      • TABLE 27     CELL ANALYSIS CONSUMABLES GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 28     CELL ANALYSIS GLOBAL MARKET, BY CONSUMABLES (2015-2023) ($MN)
      • TABLE 29     CELL ANALYSIS ASSAY KITS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 30     CELL ANALYSIS REAGENTS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 31     CELL ANALYSIS MICROPLATES GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 32     CELL ANALYSIS CONSUMABLES GLOBAL MARKET FOR CELL CULTURE, BY REGION (2015-2023) ($MN)
      • TABLE 33     CELL ANALYSIS OTHER CONSUMABLES GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 34     CELL ANALYSIS INSTRUMENTS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 35     CELL ANALYSIS INSTRUMENTS GLOBAL MARKET, BY TYPE (2015-2023) ($MN)
      • TABLE 36     CELL COUNTERS IN CELL ANALYSIS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 37     CELL ANALYSIS CELL MICROARRAYS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 38     CELL ANALYSIS CELL ISOLATION/ SEPARATION INSTRUMENTS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 39     CELL ANALYSIS CYTOMETERS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 40     CELL ANALYSIS GLOBAL MARKET FOR HIGH CONTENT SCREENING DEVICES, BY REGION (2015-2023) ($MN)
      • TABLE 41     CELL ANALYSIS GLOBAL MARKET FOR MICROFLUIDIC DEVICES, BY REGION (2015-2023) ($MN)
      • TABLE 42     CELL ANALYSIS MARKET FOR PCR DEVICES, BY REGION (2015-2023) ($MN)
      • TABLE 43     CELL ANALYSIS SEQUENCING GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 44     CELL ANALYSIS SPECTROPHOTOMETERS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 45     CELL ANALYSIS MICROSCOPY GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 46     CELL ANALYSIS OTHER INSTRUMENTS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 47     CELL ANALYSIS SOFTWARES AND SERVICES PRODUCTS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 48     CELL ANALYSIS GLOBAL MARKET, BY PROCESS OF APPLICATION, (2015-2023) ($MN)
      • TABLE 49     CELL ANALYSIS APPLICATION GLOBAL MARKET FOR CELLULAR PROCESSES, BY REGION, (2015-2023) ($MN)
      • TABLE 50     CELL ANALYSIS APPLICATION GLOBAL MARKET FOR SIGNAL TRANSDUCTION STUDIES, BY REGION (2015-2023) ($MN)
      • TABLE 51     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR CTC, BY REGION (2015-2023) ($MN)
      • TABLE 52     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR SINGLE CELL ANALYSIS, BY REGION (2015-2023) ($MN)
      • TABLE 53     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR EPIGENETIC TARGET ANALYSIS, BY REGION (2015-2023) ($MN)
      • TABLE 54     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR SUBPOPULATION CHARACTERIZATION, BY REGION (2015-2023) ($MN)
      • TABLE 55     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR DRUG AND CANDITATE SCREENING, BY REGION (2015-2023) ($MN)
      • TABLE 56     CELL ANALYSIS GLOBAL MARKET, BY FIELD OF APPLICATION,(2015-2023) ($MN)
      • TABLE 57     CELL ANALYSIS APPLICATION GLOBAL MARKET IN FORENSICS, BY REGION, (2015-2023) ($MN)
      • TABLE 58     CELL ANALYSIS APPLICATION GLOBAL MARKET IN THERAPEUTICS, BY REGION (2015-2023) ($MN)
      • TABLE 59     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR GENOMIC ANALYSIS, BY REGION (2015-2023) ($MN)
      • TABLE 60     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR STEM CELL ANALYSIS, BY REGION (2015-2023) ($MN)
      • TABLE 61     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR BIOMARKER RESEARCH, BY REGION (2015-2023) ($MN)
      • TABLE 62     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR CELL IMAGING,BY REGION (2015-2023) ($MN)
      • TABLE 63     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR DIAGNOSTICS, BY REGION (2015-2023) ($MN)
      • TABLE 64     CELL ANALYSIS GLOBAL MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2015-2023) ($MN)
      • TABLE 65     CELL ANALYSIS APPLICATION GLOBAL MARKET FOR CANCER RESEARCH, BY REGION, (2015-2023) ($MN)
      • TABLE 66     CELL ANALYSIS APPLICATION GLOBAL MARKET FOR GENETIC TESTING, BY REGION (2015-2023) ($MN)
      • TABLE 67     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR INFECTIOUS DISEASES, BY REGION (2015-2023) ($MN)
      • TABLE 68     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR IMMUNOLOGY,BY REGION (2015-2023) ($MN)
      • TABLE 69     CELL ANALYSIS APPLICATIONS GLOBAL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION (2015-2023) ($MN)
      • TABLE 70     CELL ANALYSIS GLOBAL MARKET REVENUE, BY ENDUSERS, (2015-2023) ($MN)
      • TABLE 71     HOSPITALS CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 72     ACADEMICS & RESEARCH LABORATORIES CELL ANALYSIS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 73     CELL ANALYSIS GLOBAL MARKET REVENUE FROM DIAGNOSTIC LABORATORIES, BY REGION, (2015-2023) ($MN)
      • TABLE 74     CELL ANALYSIS GLOBAL MARKET REVENUE FROM PHARMA & BIOTECH COMPANIES, BY REGION, (2015-2023) ($MN)
      • TABLE 75     CELL ANALYSIS GLOBAL MARKET REVENUE FROM CRO’S, BY REGION, (2015-2023) ($MN)
      • TABLE 76     CELL ANALYSIS GLOBAL MARKET REVENUE FROM CELL BANKS, BY REGION, (2015-2023) ($MN)
      • TABLE 77     CELL ANALYSIS GLOBAL MARKET REVENUE FROM OTHER END USERS, BY REGION, (2015-2023) ($MN)
      • TABLE 78     NORTH AMERICAN CELL ANALYSIS MARKET REVENUE, BY TECHNIQUES, (2015-2023) ($MN)
      • TABLE 79     NORTH AMERICAN MOLECULAR CELL ANALYSIS APPROACHES MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 80     NORTH AMERICAN MICROFLUIDICS AND MICROARRAY TECHNIQUES MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 81     NORTH AMERICAN IMAGE BAESD CELL ANALYSIS MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 82     NORTH AMERICAN CELL ANALYSIS MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
      • TABLE 83     NORTH AMERICAN CELL ANALYSIS MARKET REVENUE, BY CONSUMABLES, (2015-2023) ($MN)
      • TABLE 84     NORTH AMERICAN CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS, (2015-2023) ($MN)
      • TABLE 85     NORTH AMERICAN CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION, (2015-2023) ($MN)
      • TABLE 86     NORTH AMERICAN CELL ANALYSIS MARKET REVENUE, BY FIELDS OF APPLICATION, (2015-2023) ($MN)
      • TABLE 87     NORTH AMERICAN MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2015-2023) ($MN)
      • TABLE 88     NORTH AMERICAN CELL ANALYSIS MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
      • TABLE 89     EUROPE CELL ANALYSIS MARKET REVENUE, BY TECHNIQUES,(2015-2023) ($MN)
      • TABLE 90     EUROPE MOLECULAR BASED CELL ANALYSIS APPROACH MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 91     EUROPE MICROFLUIDICS AND MICROARRAY TECHNIQUES MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 92     EUROPE IMAGE BASED CELL ANALYSIS APPROACH MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 93     EUROPE CELL ANALYSIS MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
      • TABLE 94     EUROPE CELL ANALYSIS MARKET REVENUE, BY CONSUMABLES, (2015-2023) ($MN)
      • TABLE 95     EUROPE CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS, (2015-2023) ($MN)
      • TABLE 96     EUROPE CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATION, (2015-2023) ($MN)
      • TABLE 97     EUROPE CELL ANALYSIS MARKET REVENUE, BY FIELD OF APPLICATION, (2015-2023) ($MN)
      • TABLE 98     EUROPE CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2015-2023) ($MN)
      • TABLE 99     EUROPE CELL ANALYSIS MARKET REVENUE, BY ENDUSERS, (2015-2023) ($MN)
      • TABLE 100     ASIA PACIFIC CELL ANALYSIS MARKET REVENUE, BY TECHNIQUES, (2015-2023) ($MN)
      • TABLE 101     ASIA PACIFIC MOLECULAR BASED CELL ANALYSIS APPROACH MARKET REVENUE, BYTYPE, (2015-2023) ($MN)
      • TABLE 102     ASIA PACIFIC MICROFLUIDICS AND MICROARRAY TECHNIQUES MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 103     ASIA PACIFIC IMAGE BASED CELL ANALYSIS APPROACH MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 104     ASIA PACIFIC CELL ANALYSIS MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
      • TABLE 105     ASIA PACIFIC CELL ANALYSIS MARKET REVENUE, BY CONSUMABLES, (2015-2023) ($MN)
      • TABLE 106     ASIA PACIFIC CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS, (2015-2023) ($MN)
      • TABLE 107     ASIA PACIFIC CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATIONS, (2015-2023) ($MN)
      • TABLE 108     ASIA PACIFIC CELL ANALYSIS MARKET REVENUE, BY FIELDS OF APPLICATION, (2015-2023) ($MN)
      • TABLE 109     ASIA PACIFIC CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2015-2023) ($MN)
      • TABLE 110     ASIA PACIFIC CELL ANALYSIS MARKET REVENUE, BY ENDUSERS, (2015-2023) ($MN)
      • TABLE 111     ROW CELL ANALYSIS MARKET REVENUE, BY TECHNIQUES, (2015-2023) ($MN)
      • TABLE 112     ROW MOLECULAR BASED CELL ANALYSIS APPROACH MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 113     ROW MICROFLUIDICS AND MICROARRAY TECHNIQUES MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 114     ROW IMAGE BASED CELL ANALYSIS APPROACH MARKET REVENUE,BY TYPES, (2015-2023) ($MN)
      • TABLE 115     ROW CELL ANALYSIS MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
      • TABLE 116     ROW CELL ANALYSIS MARKET REVENUE, BY CONSUMABLES,(2015-2023) ($MN)
      • TABLE 117     ROW CELL ANALYSIS MARKET REVENUE, BY INSTRUMENTS, (2015-2023) ($MN)
      • TABLE 118     ROW CELL ANALYSIS MARKET REVENUE, BY PROCESS OF APPLICATIONS, (2015-2023) ($MN)
      • TABLE 119     ROW CELL ANALYSIS MARKET REVENUE, BY FIELD APPLICATIONS, (2015-2023) ($MN)
      • TABLE 120     ROW CELL ANALYSIS MARKET REVENUE, BY THERAPEUTIC AREA OF APPLICATION, (2015-2023) ($MN)
      • TABLE 121     ROW CELL ANALYSIS MARKET REVENUE, BY ENDUSERS, (2015-2023) ($MN)
      • TABLE 122     NEW PRODUCT LAUNCH (2015-2016)
      • TABLE 123     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2015-2016)
      • TABLE 124     MERGERS AND ACQUITIONS (2015-2016)
      • TABLE 125     APPROVALS (2015-2016)
      • TABLE 126     BUSINESS EXPANSION (2015-2016)
      • TABLE 127     AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 128     AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 129     AGILENT TECHNOLOGIES: TOTAL REVENUE, BY GEOGRAPHY,(2014-2016) ($MN)
      • TABLE 130     BECTON DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 131     BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 132     BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY LIFE SCIENCE SEGMENTS, (2014-2016) ($MN)
      • TABLE 133     BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 134     BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 135     BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 136     BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 137     DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 138     DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENTS,(2014-2016) ($MN)
      • TABLE 139     DANAHER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 140     GE: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 141     GE: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 142     GE: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 143     MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 144     MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 145     MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 146     OLYMPUS CORPORATION : TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 147     OLYMPUS CORPORATION : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 148     OLYMPUS CORPORATION : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 149     PERKINELMER, INC.: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 150     PERKINELMER, INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 151     PERKINELMER, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 152     PROMEGA CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 153     QIAGEN N.V.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 154     QIAGEN N.V.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 155     QIAGEN N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 156     THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 157     THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 158     THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     CELL ANALYSIS GLOBAL MARKET REVENUE, BY GEOGRAPHY(2015-2023)
      • FIGURE 2     RESEARCH METHODOLOGY: CELL ANALYSIS GLOBAL MARKET
      • FIGURE 3     CELL ANALYSIS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     CELL ANALYSIS GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     CELL ANALYSIS GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     CELL ANALYSIS GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     CELL ANALYSIS GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     CELL ANALYSIS GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     CELL ANALYSIS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
      • FIGURE 11     SINGLE CELL ANALYSIS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
      • FIGURE 12     CELL ANALYSIS GLOBAL MARKET REVENUE, BY TECHNIQUE (2015-2023) ($MN)
      • FIGURE 13     CELL ANALYSIS GLOBAL MARKET REVENUE, BY MOLECULAR APPROACHES OF TECHNIQUE (2016 V’S 2023) ($MN)
      • FIGURE 14     MICROFLUIDICS AND MICROARRAY CELL ANALYSIS GLOBAL MARKET REVENUE, BY TYPE (2016-2023) ($MN)
      • FIGURE 15     CELL ANALYSIS GLOBAL MARKET REVENUE, BY IMAGE-BASED APPROACHES OF TECHNIQUES (2016 V’S 2023) ($ MN)
      • FIGURE 16     CELL ANALYSIS GLOBAL MARKET, BY PRODUCT, (2015-2023), ($MN)
      • FIGURE 17     CELL ANALYSIS GLOBAL MARKET, BY CONSUMABLES, (2015 V’S 2023), ($MN)
      • FIGURE 18     CELL ANALYSIS GLOBAL MARKET, BY INSTRUMENTS, (2015-2023), ($MN)
      • FIGURE 19     CELL ANALYSIS GLOBAL MARKET REVENUE, BY PROCESS OF APPLICATION (2016 V’S 2023) ($MN)
      • FIGURE 20     CELL ANALYSIS GLOBAL MARKET, BY FIELD OF APPLICATION (2016 V’S 2023) ($MN)
      • FIGURE 21     CELL ANALYSIS GLOBAL MARKET, BY THERAPEUTIC AREA OF APPLICATION (2016 V’S 2023) ($MN)
      • FIGURE 22     CELL ANALYSIS GLOBAL MARKET REVENUE, BY END USERS (2016 V’S 2023) ($MN)
      • FIGURE 23     CELL ANALYSIS MARKET GLOBAL REVENUE, BY REGION (2015-2023) ($MN)
      • FIGURE 24     OUTLOOK OF NORTH AMERICAN MARKET SIZE, BY TECHNIQUES, PRODUCTS,& END-USERS (2016 V’S 2023)
      • FIGURE 25     OUTLOOK OF NORTH AMERICAN MARKET SIZE, BY APPLICATIONS,(2016 V’S 2023)
      • FIGURE 26     OUTLOOK OF EUROPEAN MARKET SIZE, BY PRODUCTS, TECHNIQUES & END-USERS (2016 V’S 2023)
      • FIGURE 27     OUTLOOK OF EUROPEAN MARKET SIZE, BY APPLICATIONS (2016 V’S 2023)
      • FIGURE 28     OUTLOOK OF ASIA PACIFIC MARKET SIZE, BY PRODUCTS, TECHNIQUES & END-USERS (2016 V’S 2023)
      • FIGURE 29     OUTLOOK OF ASIA PACIFIC MARKET SIZE, BY APPLICATIONS (2016 V’S 2023)
      • FIGURE 30     OUTLOOK OF ROW CELL ANALYSIS MARKET SIZE, BY PRODUCTS, TECHNIQUES & END-USERS (2016 V’S 2023)
      • FIGURE 31     OUTLOOK OF ROW CELL ANALYSIS MARKET SIZE, BY APPLICATIONS (2016 V’S 2023)
      • FIGURE 32     KEY GROWTH STRATEGIES (2015-2016)
      • FIGURE 33     SWOT: AGILENT TECHNOLOGIES
      • FIGURE 34     SWOT: BECTON DICKINSON AND COMPANY
      • FIGURE 35     SWOT: BIO-RAD LABORATORIES
      • FIGURE 36     SWOT: DANAHER CORPORATION
      • FIGURE 37     SWOT: GE HEALTHCARE
      • FIGURE 38     SWOT: MERCK KGAA
      • FIGURE 39     SWOT: OLYMPUS CORPORATION
      • FIGURE 40     SWOT: PERKINELMER, INC
      • FIGURE 41     SWOT: PROMEGA CORPORATION
      • FIGURE 42     SWOT: QIAGEN N V
      • FIGURE 43     SWOT:THERMOFISHER SCIENTIFIC

      LIST OF COMPANIES MENTIONED IN REPORT

      • 1     4TITUDE
      • 2     AB SCIEX
      • 3     ABBOTT LABORATORIES, INC.
      • 4     ABCAM PLC
      • 5     ABDOS
      • 6     ABNOVA CORPORATION
      • 7     ACEA BIOSCIENCE, INC
      • 8     ACTIVE MOTIF
      • 9     ADNAGEN
      • 10     ADVANCED CELL DIAGNOSTICS
      • 11     AGILENT TECHNOLOGIES, INC.
      • 12     ALERE
      • 13     ANALYTIK JENA AG
      • 14     APOCELL
      • 15     APPLIED MICROARRAYS
      • 16     AUSRAGEN
      • 17     AUXILAB S.L
      • 18     AVANTES BV
      • 19     AVEN INC
      • 20     AVIVA BIOSCIENCE
      • 21     BECTON DICKINSON AND COMPANY
      • 22     BGI
      • 23     BIBBY SCIENTIFIC LIMITED
      • 24     BIO CARE MEDICAL LLC
      • 25     BIODOT INC.
      • 26     BIOFLUIDICA
      • 27     BIOLOGICS
      • 28     BIOMERIEUX SA
      • 29     BIO-RAD LABORATORIES
      • 30     BIORON
      • 31     BIOSEARCH TECHNOLOGIES
      • 32     BIOVIEW
      • 33     BMS MICROSCOPES
      • 34     BRUKER
      • 35     CANOPUS BIOSCIENCE
      • 36     CAPP APS
      • 37     CARL ZEISS AG
      • 38     CELL SIGNALING TECHNOLOGY, INC.
      • 39     CELL-VU
      • 40     CHERRY BIOTECH
      • 41     CISBIO BIOASSAYS
      • 42     CLEARBRIDGE BIOMEDICS
      • 43     CORNING INC
      • 44     CREATV MICROTECH INC
      • 45     CYFLOGIC
      • 46     CYNVENIO BIOSYSTEMS
      • 47     CYTOGNOS S.L.
      • 48     DAAN GENE
      • 49     DANAHAR CORPORATION
      • 50     DANISH MICRO ENGINEERING
      • 51     DIAGENODE
      • 52     DISCOVERX
      • 53     DOMEL
      • 54     DRAGON LABORATORY INSTRUMENTS LTD
      • 55     EBIOSCIENCE, INC.,
      • 56     EPPENDORF
      • 57     ETALUMA, INC
      • 58     EUROFINS SCIENTIFIC
      • 59     EXIQON
      • 60     FEI COMPANY
      • 61     FLUIDGM CORPORATION
      • 62     FLUXION BIOSCIENCES
      • 63     GE HEALTHCARE
      • 64     GENEDATA AG
      • 65     GENEMED BIOTECHNOLOGIES INC
      • 66     GENERAL BIOLOGICALS
      • 67     GYROS AB
      • 68     HANDYEM
      • 69     HAUSSER SCIENTIFIC
      • 70     HEROLAB GMBH
      • 71     HETTICH LAB TECHNOLOGY
      • 72     HOFFMANN-LA ROCHE
      • 73     HORIBA, LTD.
      • 74     ILLUMINA
      • 75     IMMUNODIAGNOSTICS SYSTEMS
      • 76     JASCO
      • 77     JENA BIOSCIENCES
      • 78     JEOL, LTD.
      • 79     JASCO ANALYTICAL INSTRUMENTS
      • 80     KAPA BIOSYSTEMS
      • 81     KEYENCE CORPORATION
      • 82     KYRATEC
      • 83     LABCON
      • 84     LABNET INTERNATIONAL, INC
      • 85     LUBIO SCIENCE
      • 86     LUMINEX CORPORATION
      • 87     LW SCIENTIFIC
      • 88     MACROGEN INC
      • 89     MEDICAL ECONET
      • 90     MEIJO TECHNO
      • 91     MERCK KGAA
      • 92     METTLER-TOLEDO, INC.
      • 93     MICRO-SHOT TECHNOLOGY LTD
      • 94     MILTENYIL BIOTEC
      • 95     NANOSTRING TECHNOLOGIES
      • 96     NEW ENGLAND BIOLABS
      • 97     NIKON CORPORATION
      • 98     OLYMPUS CORPORATION
      • 99     OPTIKA SRL
      • 100     ORTHO CLINICAL DIAGNOSTICS
      • 101     ORTOALRESA
      • 102     OXFORD NANOPORE TECHNOLOGIES, LTD.
      • 103     PACIFIC BIOSCIENCES
      • 104     PANAGENE
      • 105     PARK SYSTEMS
      • 106     PERKINELMER INC
      • 107     PHEONIX
      • 108     PICOQUANT GMBH
      • 109     PROMEGA CORPORATION
      • 110     QIAGEN N.V.
      • 111     QUEST DIAGNOSTICS
      • 112     R&D SYSTEMS
      • 113     RAIN DANCE TECHNOLOGIES
      • 114     RHEONIX
      • 115     RIGAKU CORPORATION
      • 116     RR MECHATRONICS
      • 117     SACACE BIOTECHNOLOGIES
      • 118     SANYO
      • 119     SCIENION
      • 120     SCIENTIFIC SPECIALITIES INC
      • 121     SEEGENE
      • 122     SEIMENS HEALTHCARE
      • 123     SEPARATION TECHNOLOGY, INC
      • 124     SHIMADZU SCIENTIFIC INSTRUMENTS
      • 125     SIGMA LABORZENTRIFUGEN GMBH
      • 126     SOHN GMBH
      • 127     SONY BIOTECHNOLOGY
      • 128     SPRENSON BIOSCIENCE
      • 129     STEMCELL TECHNOLOGIES
      • 130     SYSMEX
      • 131     TECAN
      • 132     THE WESTERN ELECTRIC & SCIENTIFIC WORKS
      • 133     THERMOFISHER SCIENTIFIC INC
      • 134     THORLABS
      • 135     TOYO GOSEI CO., LTD
      • 136     TRIMGEN GENETIC DIAGNOSTICS
      • 137     VISION SCIENTIFIC CO LTD
      • 138     VISITRON SYSTEMS GMBH
      • 139     WATERS CORPORATION
      • 140     YOKOGAWA ELECTRIC CORPORATION
      • 141     ZYMO RESEARCH